Altimmune, Inc.
ALT
$5.61
-$0.36-6.03%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | -0.11% | -6.39% | |||
| Gross Profit | 0.11% | 6.39% | |||
| SG&A Expenses | 2.44% | -11.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.40% | -7.39% | |||
| Operating Income | -0.40% | 7.40% | |||
| Income Before Tax | -1.47% | 7.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.47% | 7.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.47% | 7.28% | |||
| EBIT | -0.40% | 7.40% | |||
| EBITDA | -0.42% | 7.32% | |||
| EPS Basic | -1.21% | 7.48% | |||
| Normalized Basic EPS | -1.19% | 7.46% | |||
| EPS Diluted | -1.21% | 7.48% | |||
| Normalized Diluted EPS | -1.19% | 7.46% | |||
| Average Basic Shares Outstanding | 0.25% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
